In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles
Authors:
- 1 February 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (2) , 378-380
Abstract
Ten benzimidazole derivatives and amphotericin B were tested in vitro against three isolates of Cryptococcus neoformans. Drug concentrations inhibiting 50% of growth (IC50s) were determined. Four derivatives, including mebendazole and albendazole, had moderately high activities (IC50 = 0.1 to 0.3 microgram/ml). Fenbendazole, however, was 10-fold more active (IC50 = 0.01 to 0.02 microgram/ml) and also 2-fold more active than amphotericin B. Ten additional clinical isolates of C. neoformans were tested against fenbendazole, mebendazole, and albendazole; similar susceptibilities were observed. Drug concentrations lethal to 90% of the cells (LC90s) were determined for two isolates. The LC90s of albendazole and mebendazole were 0.92 to 2.1 micrograms/ml, and those of fenbendazole were 0.06 to 0.07 microgram/ml; the latter are eight to ninefold lower than the LC90s of amphotericin B that were obtained. Spontaneously arising mutants displaying partial resistance to fenbendazole arose at a low frequency (5 x 10(-9).Keywords
This publication has 15 references indexed in Scilit:
- Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes — an analysisGene, 1993
- Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis cariniiAntimicrobial Agents and Chemotherapy, 1992
- Amino acid alterations in the benA (β‐tubulin) gene of Aspergillus nidulans that confer benomyl resistanceCell Motility, 1992
- Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexateMolecular Genetics and Genomics, 1991
- Activity of the Anthelmintic Benzimidazoles against Giardia lamblia In VitroThe Journal of Infectious Diseases, 1990
- Plasma and CSF Levels of Albendazole and Praziquantel in Patients with NeurocysticercosisClinical Neuropharmacology, 1990
- The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazolesInternational Journal for Parasitology, 1988
- Cryptococcosis in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- INVITRO EFFECT OF MICROTUBULE INHIBITORS ON TRICHOMONAS-VAGINALIS1985
- Mebendazole and Related Anthelmintics1982